OptimizeRx Corporation (OPRX) Gross margin 2016–2025
OptimizeRx Corporation (OPRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.3%FY2025 · since FY2016: 56.0% → 67.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.3% | +2.8 pp |
| FY2024 | 64.5% | +4.5 pp |
| FY2023 | 60.0% | -3741.7 pp |
| FY2022 | 3801.6% | +3012.6 pp |
| FY2021 | 789.0% | +733.4 pp |
| FY2020 | 55.7% | -7.1 pp |
| FY2019 | 62.8% | +5.2 pp |
| FY2018 | 57.6% | +8.5 pp |
| FY2017 | 49.1% | -6.9 pp |
| FY2016 | 56.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OPRX financial trends
OPRX RevenueOPRX Net incomeOPRX Net marginOPRX Gross profitOPRX Operating incomeOPRX Operating marginOPRX Operating cash flowOPRX Free cash flowOPRX Capital expendituresOPRX Return on equityOPRX Stock buybacksOPRX Dividends paidOPRX Total assetsOPRX Total liabilitiesOPRX Shareholders’ equityOPRX overview →